dr. perl on challenges of implementing immunotherapy in aml
Published 4 years ago • 94 plays • Length 1:10Download video MP4
Download video MP3
Similar videos
-
1:27
dr. perl on choosing the optimal therapy in aml
-
1:44
dr. perl on evolving treatment in aml
-
1:31
dr. perl on remaining challenges with car t-cell therapy
-
1:12
key challenges in immunotherapy for aml
-
2:15
challenges with immunotherapy in aml: target antigen selection, t-cell exhaustion and more
-
1:17
dr. perl discusses the impact of car t-cell therapy on all
-
0:39
dr. park on challenges with car t cells in aml
-
1:25
dr. perl on the outlook of flt3 inhibitors for aml
-
7:54
immunotherapy for aml
-
2:05
challenges with immunotherapy in aml: on-target, off-tumor toxicity
-
6:09
promising immunotherapy approaches in aml
-
1:17
alexander perl, md, on the role of immunotherapy in treating hematological malignancies
-
0:39
challenges with car t-cell therapies in aml
-
1:23
dr. perl discusses upcoming car t-cell therapies for all
-
1:29
challenges to overcome with car t-cell therapy for acute myeloid leukemia
-
2:10
alexander perl, md, on prognosis, diagnosis and treatment strategies for aml
-
4:37
immunotherapy in acute myeloid leukemia
-
3:47
the role of immunotherapy in the aml treatment landscape
-
1:14
dr. perl on car t cells in pediatric leukemia